Capricor Therapeutics
Price & Volume
Stats
See more52W Range | $3.52-$23.40 |
Market Cap | $600.7M |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $22.2M |
Revenue Growth (YoY) | -7.9% |
Gross Profit (12 Mos) | -$27.6M |
Diluted EPS | -$1.15 |
News
See moreYahoo Finance • 10 days ago
Capricor Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Yahoo Finance • 12 days ago
Capricor Therapeutics Announces Positive Data Demonstrating Long-Term Efficacy of Deramiocel for the Treatment of Duchenne Muscular Dystrophy
Yahoo Finance • 18 days ago
Capricor Therapeutics to Present Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Update on March 19
Yahoo Finance • 22 days ago
Capricor Therapeutics to Present at Leerink’s Global Healthcare Conference 2025
About
CEO | Dr. Linda Marbán Ph.D. |
CFO | Mr. Anthony J. Bergmann M.B.A. |
Address | 10865 Road to the Cure, San Diego, CA, United States, 92121 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 0 |
